Introduction
MS is most common in people of northern European ancestry. It has been concluded by many that genetics are an important factor in disease expression; however, genetics alone are not enough to guarantee the development of MS. Monozygotic twin studies indicate a clinical concordance rate between twenty and thirty percent [1] , compared with a two percent to five percent same-sex fraternal twin rate. The National MS Society states that when a sibling or parent has MS, the chance of developing MS is "1 in 40" [2] . It appears that some environmental factor is required to interact with genetics to trigger the onset of MS. Some environmental agents that have been studied as a possible cofactor in the expression of MS include viruses, hormones, vitamin D deficiency, UVB deficiency, diet, smoking, and others [3] . Studying the effects of environment on disease expression can be perplexing. Factors such as length of time of exposure to different factors, climate, migration, and occupation are all potential confounders.
A genetic link to MS may partially explain the geographic distribution of the disease as Caucasoid races tended to migrate towards the temperate climates [4] . An interesting feature of MS is that it seems to have an age of susceptibility. Migration studies have discovered that age of MS risk is around the age of pubescence [1] . If a person moves from a low-risk area to a high-risk area before pubescence, the person will be susceptible to the level of risk in that new high-risk area. Dean and Elian [5] found that immigrants to England from Asia and the Caribbean had an increased risk for MS if they moved to England prior to 15 years of age. This finding adds strength to the argument that some environmental variable must have a role to play in the development of MS.
In 1877, Charcot was the first to publish a paper that recognized that the prevalence of MS was not uniform. He discovered that, at the time, there appeared to be a higher prevalence of MS in France compared with Germany or England [6] . Since that time, numerous prevalence studies have been published which suggest that a north-south gradient of MS prevalence appears to exist in the northern hemisphere. While there is evidence to suggest that this gradient is disappearing in some countries [7] , a recent metaanalysis by Simpson Jr. et al. [8] shows that on a global scale,
Method
The search terms "multiple sclerosis and prevalence" and "multiple sclerosis and epidemiology" were applied to the following data bases: Where possible studies which used McDonald or Poser criteria were selected. 57% of the prevalence studies used either Poser or McDonald criteria. The remainder of the studies used population surveys, older diagnostic criteria such as Bauer, Rose, Allison and Millar, and Schumacher, or unknown diagnostic criteria. With the above filters (including English language studies only) and search criteria applied, we found 131 prevalence data sets (geocases) that were analyzed with descriptive statistics spatial statistical analysis tools. Table 1 shows a sample of the MS geocases and the Case Ascertainment Methods and Criteria for Diagnosis. Table 2 shows a sample of the area studied in the MS prevalence studies as well as the latitude, longitude, and prevalence rates per 100,000. The sample data set table provides an example of the center-point latitude and longitude used for the relevant studies. If the study population is defined by a city, then the latitude and longitude are those generally accepted for the city to the nearest minute. When larger regions were studied such as at a province, state, region or country level, and a city-level, center-point for the area will be calculated and the latitude and longitude of that center-point to the nearest minute will be used. The areas in parentheses are the approximate center-point of the area.
Spatial statistical analyses was completed using the ESRI ArcGIS-ArcInfo [12] spatial statistics toolbox [13] . The specific analyses contained in each category that were used in the data analysis are listed below.
(ii) Pattern Analysis 
Results
Using the search criteria outlined in Methods section, we found 131 geocases that met the criteria. Table 3 shows the descriptive statistics containing the 131 geocases. Of note is the mean global prevalence rate of MS at 67.83 per 100,000 and the maximum value of 350 per 100,000 (Canada).
Spatial Statistics
To examine the data from the 131 geocases visually, Arc GIS 9.3.1 was used to generate maps on a global level. What is immediately evident from the maps in Figures 1 and 2 is that the majority of the geo-cases represent prevalence studies from Europe. We can see, in Figure 1 , Hot Spots, Mean Center, Central Feature, and the Standard Distance of the 131 geo-cases for MS prevalence in the world. The Mean Center of the 131 geo-cases appears to be in northern Africa at approximately 30 ∘ , 22 N and 11 ∘ , 4 E. This center merely represents the Mean Center location of the average of the and values for the geo-cases and should not be confused with a geographic center for MS prevalence. This information tells us that the majority of studies used in this research were based on research from the northern hemisphere. Similar to Mean Center, Central Feature represents a point that is the smallest distance to all the other points. The Central Feature in Figure 1 is located in approximately the middle of Italy at 42 ∘ , 0 N and 13 ∘ , 1 E. The Standard Distance which is the transparent circle encircling all of Europe and Africa again demonstrates that the majority of the geo-cases are representative of data from European countries.
The Gi statistic (hot spot analysis) examines whether features with high or low values tend to cluster in an area. This statistic tool will examine whether neighbouring points have similar values; if they are similar, then they are considered hot spots. A score is used to determine the statistical significance of the relationship between the neighbours. A high positive score as seen in most of Europe and Canada represents a score which is more than 2.58 SD from the mean. The areas that are less than −2.58 SD represent areas of low prevalence of MS. Figure 2 shows a spatial analysis done to examine for clusters and outliers. Using the Cluster and Outlier Analysis (Anselin Local Morans ) tool, the data is analyzed for values of similar magnitude and those which would be very dissimilar (outliers). This index (Local Morans ) then has a score calculated to determine the significance. outliers are found in Eastern Europe, South America, and Africa. Figure 3 shows cluster analysis with rendering and a directional distribution of MS prevalence. In addition to seeing the clusters with color-weighting, the directional distribution (Standard Deviational Ellipse) shows where the majority of the geocases are in Europe and trending towards Canada and south-east Asia.
Pattern Analysis
Using ArcGIS 9.3, a statistical test of pattern analysis was performed to quantify the relationships of the geocases. While mapping the geocases, as shown in Figures 1-3 , gives a sense of patterns, statistically testing using pattern analysis quantifies the probabilities that the visual relationships did not merely occur by chance. The four pattern analyses performed on the 131 geocases were Average Nearest Neighbour Distance, High/Low Clustering, Spatial Autocorrelation, and Multidistance Spatial Cluster Analysis.
Average Nearest Neighbour: this statistical tool measures the distance between the centroid of a geocase and its nearest neighbour's geocase centroid. These distances are then averaged to determine if a cluster exists relative to a random distribution. An index ratio is created (observed distance divided by expected distance). An index less than 1 is trending towards a cluster whereas an index greater than 1 is trending towards dispersion. The Average Nearest Neighbour test results with our 131 geocases revealed that significant clustering exists: 0.67 (index), = −7.29 SD, < 0.01. 
Discussion
Although Kurtzke did revisit the global prevalence scale for MS when he reexamined more recent European data, the original, three-zone scale of High, Medium, and Low remains the same. When our 131 prevalence studies were examined, over forty percent of the prevalence rates were over 50 per 100,000. It is clear that Kurtzke's [10] original divisions of MS prevalence into high zones (30-80 per 100,000), medium Zones (5-25 per 100,000), and low zones (<5 per 100,000) may not be granular enough to account for more recent prevalence studies showing MS prevalence rates in Canada over 300 per 100,000. As a result of this research, it is recommended that the global prevalence scale be expanded into a five-zone scale based on the results from the spatial analyses in Figures 1-3 . The prevalence scales generated by ArcGIS divided the five prevalence zones into (rounded): 0-13; 13-38; 38-70; 70-170; 170-350 per 100,000. The categories representing these more granular divisions for global MS prevalence zones should be very high (170-350 per 100,000), high (70-170 per 100,000), medium (38-70 per 100,000), low (13-38 per 100,000), and very low (0-13 per 100,000).
It is necessary to expand from a three-zone classification system to a five-zone classification system to avoid grouping together countries with prevalence rates which are incomparable. In a three-zone classification, countries such as England, Germany, and Switzerland which have prevalence rates between 100 and 150 per 100,000 would likely be ranked as "high" and in the same category as countries such as Canada, Norway, Sweden, Scotland, and Ireland which have prevalence rates ranging between 150 and 350 per 100,000. A similar argument is made for adding a "very low" category as Multiple Sclerosis International 7 to not group countries such as Malaysia, Thailand, and most of the African countries with a zero to very low prevalence rates with countries such as Argentina, Uruguay, and the north island of New Zealand which have prevalence rates between 13 and 38 per 100,000.
Whether due to actual increases in MS incidence rates or better diagnostic practices in some countries, it is likely that in the future, the proposed five-zone classification scale for global MS prevalence will be even more important to capture and effectively compare countries with higher MS prevalence rates than previously reported. Table 4 
